CANDACE STARON: Open Payments
NPI 1518622091 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 40 payments from 15 companies in 2025. Trend: 2023 $2,172 · 2024 $1,559 · 2025 $974
Food & beverage: $974
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $211 |
| ABBVIE INC. | 10 | $157 |
| Arcutis Biotherapeutics, Inc. | 5 | $95 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Incyte Corporation | 3 | $73 |
| Lilly USA, LLC | 2 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Janssen Biotech, Inc. | 3 | $52 |
| UCB, Inc. | 1 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $35 |
Products named: NEMLUVIO, Zoryve, RINVOQ, SKYRIZI, OPZELURA, DUPIXENT, TREMFYA, ILUMYA.
Industry payments across FL — which companies pay providers there.
